As of today (2024-04-25), ChemoCentryx's share price is $51.99. ChemoCentryx's Tangible Book per Share of Jun. 2022 for the quarter that ended in Jun. 2022 was $3.32. Hence, ChemoCentryx's Price to Tangible Book Ratio of today is 15.68.
The historical rank and industry rank for ChemoCentryx's Price-to-Tangible-Book or its related term are showing as below:
CCXI'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.56 Med: 5.13 Max: 41.25
Current: 15.66
During the past 13 years, ChemoCentryx's highest Price to Tangible Book Ratio was 41.25. The lowest was 1.56. And the median was 5.13.
CCXI's Price-to-Tangible-Book is not ranked
in the Biotechnology industry.
Industry Median: 2.67
vs CCXI: 15.66
ChemoCentryx Price-to-Tangible-Book Historical Data
The historical data trend for ChemoCentryx's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ChemoCentryx's Price-to-Tangible-Book
For the Biotechnology subindustry, ChemoCentryx's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoCentryx's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ChemoCentryx's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where ChemoCentryx's Price-to-Tangible-Book falls into.
ChemoCentryx Price-to-Tangible-Book Calculation
ChemoCentryx's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
ChemoCentryx Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of ChemoCentryx's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
ChemoCentryx Inc is a biopharmaceutical company involved in the discovery, development, and commercialization of orally administered drugs to treat rare diseases, inflammatory disorders, autoimmune diseases, and cancer. The company's approach is to target the chemoattractant system, defined as a network of molecules (for example, chemokine ligands, their associated receptors, and chemoattractant receptors) known to cause inflammation. The targeted therapeutic areas are an antineutrophil cytoplasmic antibody, atypical hemolytic uremic syndrome, immunoglobulin A-mediated nephropathy (rare diseases category), pancreatic cancer, chronic kidney disease, psoriasis, rheumatoid arthritis, asthma, Crohn's disease, inflammatory bowel disease, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCXI has been successfully added to your 